New state-of-the-art facility to develop immunotherapy assets to address unmet needs in cancer treatment
SINGAPORE -
Media OutReach - 28 June 2023 –
Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma treatment, today announced the official opening of its latest Good Manufacturing Practice (GMP) facility in Singapore.